Physicochemical Properties
| Molecular Formula | C67H80N14O19S |
| Molecular Weight | 1417.50 |
| CAS # | 936728-13-1 |
| Related CAS # | G7-18NATE TFA |
| SMILES | C([C@@H]1NC(CSC[C@H](NC([C@]2([H])CCCN2C([C@@H](NC([C@@]([H])(NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC([C@@H](NC1=O)CC1C=CC=CC=1)=O)CCC(=O)O)=O)=O)CC1C=CC(=CC=1)O)=O)CC(=O)O)=O)CC(=O)N)=O)[C@H](O)C)=O)CC1C=CC=CC=1)=O)=O)C(=O)N)=O)C1=CNC2=CC=CC=C12 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | G7-18NATE (10 μM, 24 h) inhibits the migration of MDA-MB-468 cells[2]. |
| References |
[1]. Evaluation of Cyclic Peptide Inhibitors of the Grb7 Breast Cancer Target: Small Change in Cargo Results in Large Change in Cellular Activity. Molecules. 2019 Oct 17;24(20):3739. [2]. GRB7 is required for triple-negative breast cancer cell invasion and survival. Breast Cancer Res Treat. 2012 Jun;133(2):607-15. |
Solubility Data
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 0.7055 mL | 3.5273 mL | 7.0547 mL | |
| 5 mM | 0.1411 mL | 0.7055 mL | 1.4109 mL | |
| 10 mM | 0.0705 mL | 0.3527 mL | 0.7055 mL |